Skip to main content

M Mar Mañu Pereira

Head of research Lab in rare anemia disorders - Senior researcher Scientific Director of ERN-EuroBloodNet Coordinator of the European platforms for patients registries in hematology ENROL and in rare anemia disorders RADeep

Institutions of which they are part

Main researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

M Mar Mañu Pereira

Institutions of which they are part

Main researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Head of research Lab in rare anemia disorders - Senior researcher Scientific Director of ERN-EuroBloodNet Coordinator of the European platforms for patients registries in hematology ENROL and in rare anemia disorders RADeep

Head of research Lab in rare anemia disorders at VHIR - 2018 - Currently
Institut de Recerca contra la Leucèmia Josep Carreras - 2016-2018
Institut d'Investigacions Biomèdiques August Pi i Sunyer / Hospital Clínic de Barcelona - 2002-2016
Dr in BioMedicine 2009

Projects

ERICA - European Rare dIsease research Coordination and support Action

IP: M Mar Mañu Pereira
Collaborators: Claire Diot, Raquel Mosull del Campo
Funding agency: EUROPEAN COMMISSION
Funding: 105250
Reference: ERICA_H2020-SC1-BHC-2020
Duration: 01/03/2021 - 31/08/2025

GENOMED4ALL - Genomics and Personalized Medicine for all though Artificial Intelligence in Haematological Diseases

IP: M Mar Mañu Pereira
Collaborators: Reidel , Sara Isabel, Amira Idrizovic , Sara Isabel Reidel
Funding agency: EUROPEAN COMMISSION
Funding: 434000
Reference: GENOMED4ALL_H2020-SC1-FA-DTS-2018-20
Duration: 01/01/2021 - 30/06/2025

Erythrocytes properties and viability in dependence of flow and extra-cellular environment (EVIDENCE)

IP: M Mar Mañu Pereira
Collaborators: Amira Idrizovic
Funding agency: EUROPEAN COMMISSION
Funding: 250904.88
Reference: EVIDENCE_H2020_MSCA-ITN2019
Duration: 01/01/2020 - 31/12/2023

European Rare Blood Disorders Platform - ENROL

IP: M Mar Mañu Pereira
Collaborators: Claire Diot
Funding agency: EUROPEAN COMMISSION
Funding: 93954.6
Reference: ENROL_HP-PJ-01-2019
Duration: 01/06/2020 - 31/05/2023

Related news

The REACH5 study confirms that the efficacy and safety results observed in previous studies are maintained after three years of follow-up.

In-depth knowledge of tumours helps identify specific alterations and enables the provision of targeted therapies for each patient.

The charitable initiative created in honor of Pol is supporting a research project aimed at identifying therapeutic targets to treat a rare type of leukemia.

Related professionals

Lastiri González, Ernesto Alejand

Lastiri González, Ernesto Alejand

Predoctoral researcher
Physiology and Pathophysiology of the Digestive Tract
Read more
Cabrera Capelo, Adriana Jackeline

Cabrera Capelo, Adriana Jackeline

Postdoctoral researcher
Rheumatology
Read more
Sara Isabel Reidel

Sara Isabel Reidel

Research technician
Childhood Cancer and Blood Disorders
Read more
Débora Ferrate Navarro

Débora Ferrate Navarro

Purchase and Biddings Unit
Finance Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.